arrow
P

Paola Di Nardo

irccs aviano (cro)
H指数:9
被引数:840

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Triplet chemotherapy combined with anti Epidermal Growth Factor Receptor treatment in RAS wild-type colorectal cancer: a network metanalysis

三联化疗联合抗表皮生长因子受体治疗RAS野生型结直肠癌:一项网络Meta分析

2026-03-010
PRE
Prognostic role of macrophage infiltration and monocyte-to-lymphocyte ratio in stage III colon cancer: The MIRROR study

巨噬细胞浸润和单核细胞与淋巴细胞比值在III期结肠癌中的预后作用:MIRROR研究

2024-09-010
PRE
Assessing interstitial lung disease (ILD) risk in metastatic breast cancer (MBC): A comprehensive meta and network analysis of antibody-drug conjugates (ADCs) compared to available treatment options beyond first-line (1L)

评估转移性乳腺癌(MBC)中特发性肺间质病变(ILD)风险:抗体偶联物(ADCs)与现有一线(1L)后治疗方案比较的全面Meta分析和网络分析

2024-09-010
PRE
Clinical and biological predictors of lymph node involvement in patients with early breast cancer for adjuvant treatment personalization
2023-03-010
PRE
Cell-free DNA (cfDNA) workflow for the risk definition of dose-limiting and recurrent neutropenia in patients treated with first-line endocrine therapy (ET) and cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) for metastatic breast cancer (MBC)
2021-09-010
OAAI
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study
2021-01-0125
PREAI
The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer
2020-11-019
PREAI
Predictors of relative dose intensity and early dose reduction in patients with metastatic breast cancer treated with palbociclib and endocrine therapy
2020-02-150
PRE